Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Discontinuation Antipsychotic prophylaxis Dementia
Discontinuation of dose for reducing
Discontinuation symptoms when switching
Discontinuation syndrome, donepezil
Disinhibition benzodiazepines clinical implications incident rates mechanism risk factors subjective reports
disruptive mood dysregulation disorder (DMDD), bipolar disorder relationship
Disruptive mood dysregulation disorder relationship
Distribution of drugs, changes with old age
disulfiram (Antabuse), preventing relapse after alcohol detoxification
Diuretics, lithium interaction
Diversion and misuse of prescribed drugs opioids stimulants for ADHD in adults
Donepezil alzheimerâ™s disease treatment for tardive dyskinesia
Dopaminergic agents and dopamine partial agonists, possible effects on impulse control disorders
Dose and psychotropic effects of caffeine
Dose-related adverse drug effects, increased in hepatic impairment
Dose tolerability
Dosing Clozapine initiation schedules Initiation of clozapine in the community
Dosing and formulations
Dosing of paliperidone long-acting injection 3-monthly
Dosing recommendations for different routes of ketamine administration and intranasal esketamine in treatment-resistant depression
Dosing regimen for olanzapine
Driver and Vehicle Licensing Agency (DVLA), UK
Driving and psychotropic medicines Driving and psychotropic medicines duty of driver duty of prescriber effects of mental illness medication-induced sedation
Driving impairment
Driving restrictions, people with epilepsy
Dronabinol, weight restoration in anorexia nervosa
Droperidol
Drug-drug interactions
Drug half-life
Drug-induced excited states Drug-induced excited state hyperthermia risk identification illicit and misused drugs illicit drugs management outcomes pathophysiology restraint risk